{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T06:23:42Z","timestamp":1787379822320,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09827-6","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:37:43Z","timestamp":1787377063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cIL-40: A novel immunoregulatory axis at the crossroads of inflammation, tissue remodeling, and cancer immunity\u201d"],"prefix":"10.1007","volume":"74","author":[{"given":"Parisa","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Mozaffari-Jovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tola Abdulsattar","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Tavassoli","family":"Razavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Javanmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsane","family":"Fadaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Doulabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Alireza","family":"Esmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"9827_CR1","doi-asserted-by":"publisher","unstructured":"Zingaretti C, Arig\u00f2 M, Cardaci A, Moro M, Crosti M, Sinisi A, et al. Identification of new autoantigens by protein array indicates a role for IL4 neutralization in autoimmune hepatitis. Mol Cell Proteom MCP. 2012;11(12):1885\u201397. https:\/\/doi.org\/10.1074\/mcp.M112.018713.","DOI":"10.1074\/mcp.M112.018713"},{"key":"9827_CR2","doi-asserted-by":"publisher","unstructured":"Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, et al. Identification of IL-40, a Novel B Cell-Associated Cytokine. J Immunol Baltim Md 1950. 2017;199(9):3326\u201335. https:\/\/doi.org\/10.4049\/jimmunol.1700534.","DOI":"10.4049\/jimmunol.1700534"},{"key":"9827_CR3","doi-asserted-by":"publisher","unstructured":"Navr\u00e1tilov\u00e1 A, Andr\u00e9s Cerezo L, Hulejov\u00e1 H, Be\u010dv\u00e1\u0159 V, Tom\u010d\u00edk M, Komarc M, et al. IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis. Front Immunol. 2021;12:745523. https:\/\/doi.org\/10.3389\/fimmu.2021.745523.","DOI":"10.3389\/fimmu.2021.745523"},{"key":"9827_CR4","doi-asserted-by":"publisher","unstructured":"Guggino G, Rizzo C, Mohammadnezhad L, Lo Pizzo M, Lentini VL, Di Liberto D, et al. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. RMD Open. 2023;9(2). https:\/\/doi.org\/10.1136\/rmdopen.2022.002738","DOI":"10.1136\/rmdopen.2022.002738"},{"key":"9827_CR5","unstructured":"Al Rubaye AM, Sharquie IK, Gorial FI. Serum interleukin 40: an innovative diagnostic biomarker for patients with systemic lupus erythematosus. Med J Malaysia. 2023;78(5):609\u201315."},{"key":"9827_CR6","doi-asserted-by":"publisher","unstructured":"Rizzo C, La Barbera L, Lo Pizzo M, Camarda F, Mohammadnezhad L, Dieli F, et al. Potential involvement of IL-40 in kidney disease associated to systemic lupus erythematosus. Lupus. 2025;34(11):1178\u201383. https:\/\/doi.org\/10.1177\/09612033251361037","DOI":"10.1177\/09612033251361037"},{"issue":"8","key":"9827_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41577-021-00506-1","volume":"21","author":"KE Huus","year":"2021","unstructured":"Huus KE, Petersen C, Finlay BB. Diversity and dynamism of IgA\u2212 microbiota interactions. Nat Rev Immunol. 2021;21(8):514\u201325.","journal-title":"Nat Rev Immunol"},{"key":"9827_CR8","doi-asserted-by":"publisher","unstructured":"Cai S, Li X, Zhang C, Jiang Y, Liu Y, He Z, et al. Inhibition of Interleukin-40 prevents multi-organ damage during sepsis by blocking NETosis. Crit Care Lond Engl. 2025;29(1):29. https:\/\/doi.org\/10.1186\/s13054-025-05257-2 .","DOI":"10.1186\/s13054-025-05257-2"},{"key":"9827_CR9","doi-asserted-by":"publisher","unstructured":"Tan H, Wang H, Zhou X, Duan J, Yang X. Interleukin-40 as a biomarker of mortality risk in patients with severe pneumonia. Front Immunol. 2026;17:1804357. https:\/\/doi.org\/10.3389\/fimmu.2026.1804357 .","DOI":"10.3389\/fimmu.2026.1804357"},{"key":"9827_CR10","doi-asserted-by":"publisher","unstructured":"Bagriacik U, Karakus R, Yaman M, Oruklu N, Araz M, Kalayci Z, et al. Increased serum levels of IL-40 are associated with IgA and NETosis biomarkers in Covid-19 patients: IL-40 and infectious diseases. PLoS ONE. 2025;20(5):e0321578. https:\/\/doi.org\/10.1371\/journal.pone.0321578\u00a0.","DOI":"10.1371\/journal.pone.0321578"},{"issue":"1","key":"9827_CR11","first-page":"2789","volume":"7","author":"EM Idan","year":"2024","unstructured":"Idan EM. Critical Roles of IL-40 and IL-41 in the Determination of the Severity of Hydatid Cyst Infection in Iraqi Patients. Al-Rafidain J Med Sci ISSN. 2024;7(1):2789\u20133219.","journal-title":"Al-Rafidain J Med Sci ISSN"},{"key":"9827_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/annrheumdis-2021-eular.3792","volume":"80","author":"C Rizzo","year":"2021","unstructured":"Rizzo C, Pizzo ML, Mohammadnezhad L, Lentini V, Di Liberto D, Grasso G, et al. POS0177 Potential involvement of IL-40 and IL-40-producing cells in primary Sjogren\u2019s syndrome (pSS) and pSS-associated lymphoma. Ann Rheum Dis. 2021;80:301\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9827_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.32768\/abc.5801274963-802","volume":"12","author":"SA Hameed","year":"2025","unstructured":"Hameed SA, Abed RM. The Elevated Serum Interleukin-40 Levels and Gene Expression as Novel Biomarkers in Iraqi Women with Breast Cancer: IL-40 as a biomarker in Iraqi BC. Arch Breast Cancer. 2025;12(4):448\u201356.","journal-title":"Arch Breast Cancer"},{"issue":"03","key":"9827_CR14","first-page":"1379","volume":"53","author":"RY Ababil","year":"2024","unstructured":"Ababil RY, Mouruj AA. Estimation of the level of serum IL-40 and IL-41 in Chronic Myeloid Leukemia of Iraqi Patients. Cuest Fisioter. 2024;53(03):1379\u201393.","journal-title":"Cuest Fisioter"},{"key":"9827_CR15","doi-asserted-by":"publisher","unstructured":"Bashi MA, Ad\u2019hiah AH. Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia. Gene. 2024;904:148214. https:\/\/doi.org\/10.1016\/j.gene.2024.148214\u00a0","DOI":"10.1016\/j.gene.2024.148214"},{"key":"9827_CR16","doi-asserted-by":"publisher","unstructured":"Kadhim NT, Abed RM. Peripheral blood mRNA expression of IL37, IL1F10, and C17orf99 genes is altered in patients with B-acute lymphoblastic leukemia: a case-control study. Mol Biol Rep. 2026;53(1):926. https:\/\/doi.org\/10.1007\/s11033-026-12127-9 .","DOI":"10.1007\/s11033-026-12127-9"},{"key":"9827_CR17","doi-asserted-by":"publisher","unstructured":"Li A, Wong KCY, Huang D, Chen F, Li H, Gao X, et al. Unveiling Interleukin-40: A Novel Regulator of Macrophage and B Cell Function in Allergic Asthma. Int J Biol Sci. 2026;22(11):6115\u201331. https:\/\/doi.org\/10.7150\/ijbs.128164 .","DOI":"10.7150\/ijbs.128164"},{"key":"9827_CR18","doi-asserted-by":"publisher","unstructured":"Ibrahim RK, Mahmmod HM, Majeed ME. Immune-Endocrine crosstalk in hypertensive overweight men: Dysregulation of IL-17 and IL-40-mediated inflammatory pathways. Egypt J Immunol. 2026;33(3):1\u20138. https:\/\/doi.org\/10.55133\/eji.330301.","DOI":"10.55133\/eji.330301"},{"key":"9827_CR19","doi-asserted-by":"publisher","unstructured":"Nussrat SW, Ad\u2019hiah AH. Interleukin-40 is a promising biomarker associated with type 2 diabetes mellitus risk. Immunol Lett. 2023;254:1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2023.01. .006 PubMed PMID: 36640967.","DOI":"10.1016\/j.imlet.2023.01"},{"key":"9827_CR20","doi-asserted-by":"publisher","unstructured":"Zhang C, Wei X, Omenn GS, Zhang Y. Structure and Protein Interaction-Based Gene Ontology Annotations Reveal Likely Functions of Uncharacterized Proteins on Human Chromosome 17. J Proteome Res. 2018;17(12):4186\u201396. https:\/\/doi.org\/10.1021\/acs.jproteome.8b00453.","DOI":"10.1021\/acs.jproteome.8b00453"},{"key":"9827_CR21","doi-asserted-by":"publisher","unstructured":"Catalan-Dibene J, McIntyre LL, Zlotnik A. Interleukin 30 to Interleukin 40. J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res. 2018;38(10):423\u201339. https:\/\/doi.org\/10.1089\/jir.2018.0089.","DOI":"10.1089\/jir.2018.0089"},{"key":"9827_CR22","doi-asserted-by":"publisher","unstructured":"Wang W, Zhao J, Wu S, Fu J, Zhang Y, Peng W. Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities. Sci Rep. 2024;14(1):28945. https:\/\/doi.org\/10.1038\/s41598-024-80104-y.","DOI":"10.1038\/s41598-024-80104-y"},{"key":"9827_CR23","doi-asserted-by":"publisher","unstructured":"Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus. 2022;14(10):e30330. https:\/\/doi.org\/10.7759\/cureus.30330.","DOI":"10.7759\/cureus.30330"},{"key":"9827_CR24","doi-asserted-by":"publisher","unstructured":"Choi MY, Costenbader KH. Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development. Front Immunol. 2022;13:890522. https:\/\/doi.org\/10.3389\/fimmu.2022.890522.","DOI":"10.3389\/fimmu.2022.890522"},{"issue":"16","key":"9827_CR25","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.3390\/jcm14165714","volume":"14","author":"E Pagkopoulou","year":"2025","unstructured":"Pagkopoulou E, Loutradis C, Papaioannou M, Daoudaki M, Stangou M, Dimitroulas T. Autoantibodies in systemic lupus erythematosus: diagnostic and pathogenic insights. J Clin Med. 2025;14(16):5714.","journal-title":"J Clin Med"},{"issue":"3","key":"9827_CR26","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/cei\/uxac090","volume":"210","author":"NM de Gruijter","year":"2022","unstructured":"de Gruijter NM, Jebson B, Rosser EC. Cytokine production by human B cells: role in health and autoimmune disease. Clin Exp Immunol. 2022;210(3):253\u201362.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"9827_CR27","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1136\/annrheumdis-2019-216591","volume":"80","author":"M Infantino","year":"2021","unstructured":"Infantino M, Manfredi M, Bizzaro N. European League against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist\u2019s point of view. Ann Rheum Dis. 2021;80(12):e188\u2013188.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"9827_CR28","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.3390\/ijms20236021","volume":"20","author":"K Ma","year":"2019","unstructured":"Ma K, Du W, Wang X, Yuan S, Cai X, Liu D, et al. Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus. Int J Mol Sci. 2019;20(23):6021.","journal-title":"Int J Mol Sci"},{"key":"9827_CR29","doi-asserted-by":"crossref","unstructured":"Abdullah WL, Abed RM. Association of IL-37 and IL-40 with systemic lupus erythematosus in female Iraqi patients: Association of IL-37 and IL-40 with systemic lupus erythematosus in female Iraqi patients. Iraqi J Mark Res Consum Prot. 2023;15(2):31\u20138.","DOI":"10.28936\/jmracpc15.2.2023.(4)"},{"issue":"2","key":"9827_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5114\/reum.2018.75523","volume":"56","author":"M Ostrowska","year":"2018","unstructured":"Ostrowska M, Ma\u015bli\u0144ski W, Prochorec-Sobieszek M, Nieciecki M, Sudo\u0142-Szopi\u0144ska I. Cartilage and bone damage in rheumatoid arthritis. Reumatologia. 2018;56(2):111\u201320. https:\/\/doi.org\/10.5114\/reum.2018.75523 . PubMed PMID: 29853727; PubMed Central PMCID: PMC5974634.","journal-title":"Reumatologia"},{"key":"9827_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750753","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol. 2021;12:750753.","journal-title":"Front Immunol"},{"issue":"4","key":"9827_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejr.2022.07.007","volume":"44","author":"ZA Al Ghuraibawi","year":"2022","unstructured":"Al Ghuraibawi ZA, Sharquie IK, Gorial FI. Diagnostic potential of interleukin-40 (IL-40) in rheumatoid arthritis patients. Egypt Rheumatol. 2022;44(4):377\u201380.","journal-title":"Egypt Rheumatol"},{"key":"9827_CR33","doi-asserted-by":"publisher","unstructured":"O\u011fuzman H, Pekdiker M. IL-40 levels in treatment-naive and methotrexate-treated rheumatoid arthritis patients. Turk J Med Sci. 2025;55(3):658\u201365. https:\/\/doi.org\/10.55730\/1300-0144.6013.","DOI":"10.55730\/1300-0144.6013"},{"key":"9827_CR34","doi-asserted-by":"publisher","unstructured":"Ahmadi P, Mahmoudi M, Kheder RK, Faraj TA, Mollazadeh S, Abdulabbas HS, et al. Impacts of Porphyromonas gingivalis periodontitis on rheumatoid arthritis autoimmunity. Int Immunopharmacol. 2023;118:109936. https:\/\/doi.org\/10.1016\/j.intimp.2023.109936.","DOI":"10.1016\/j.intimp.2023.109936"},{"key":"9827_CR35","doi-asserted-by":"publisher","unstructured":"Ahmadi P, Janzadeh A, Honardoost M, Taherkhani S, Doyle D, Mojarad N. The role of IL-39 in autoimmune diseases: From general to immunopathogenesis. Cytokine. 2025;192:156969. https:\/\/doi.org\/10.1016\/j.cyto.2025.156969.","DOI":"10.1016\/j.cyto.2025.156969"},{"key":"9827_CR36","doi-asserted-by":"publisher","unstructured":"Cerezo LA, Navr\u00e1tilov\u00e1 A, Kuklov\u00e1 M, Prokopcov\u00e1 A, Baloun J, Krop\u00e1\u010dkov\u00e1 T, et al. IL-40 is up-regulated in the synovial fluid and cartilage of osteoarthritis patients and contributes to the alteration of chondrocytes phenotype in vitro. Arthritis Res Ther. 2024;26(1):146. https:\/\/doi.org\/10.1186\/s13075-024-03372-. z","DOI":"10.1186\/s13075-024-03372-"},{"key":"9827_CR37","doi-asserted-by":"publisher","unstructured":"Mohsen Hammad DB, Muslim Al-Ameedy FM. Investigating the Role of Circular RNAs Circ_0003972 and Circ-PTPN22 in Regulating Cytokine Expression in Postmenopausal Women with Osteoarthritis. Iran J Pathol. 2026;21(3):382\u20139. https:\/\/doi.org\/10.22034\/ijp.2026.2066696.3492.","DOI":"10.22034\/ijp.2026.2066696.3492"},{"key":"9827_CR38","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/annrheumdis-2023-eular.5824","volume":"82","author":"A Navr\u00e1tilov\u00e1","year":"2023","unstructured":"Navr\u00e1tilov\u00e1 A, Prajzlerov\u00e1 K, Petrovsk\u00e1 N, Pavelka K, Vencovsk\u00fd J, \u0160enolt L, et al. POS1049 Interleukin 40 is increased in the serum of individuals at risk of rheumatoid arthritis and stimulates an inflammatory response in mononuclear cells via NfKb. Ann Rheum Dis. 2023;82:842.","journal-title":"Ann Rheum Dis"},{"key":"9827_CR39","doi-asserted-by":"crossref","unstructured":"Bani-Wais DFN, Ad\u2019hiah AH. A novel intergenic variant, rs2004339 A\/G, of the gene encoding interleukin-40, C17orf99, is associated with risk of rheumatoid arthritis in Iraqi women. Mol Immunol. 2023;164:39\u201346.","DOI":"10.1016\/j.molimm.2023.11.002"},{"key":"9827_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/eos.12536","volume":"126","author":"R Jonsson","year":"2018","unstructured":"Jonsson R, Brokstad KA, Jonsson MV, Delaleu N, Skarstein K. Current concepts on Sj\u00f6gren\u2019s syndrome\u2013classification criteria and biomarkers. Eur J Oral Sci. 2018;126:37\u201348.","journal-title":"Eur J Oral Sci"},{"issue":"3","key":"9827_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s40744-021-00334-8","volume":"8","author":"Z Liu","year":"2021","unstructured":"Liu Z, Chu A. Sj\u00f6gren\u2019s syndrome and viral infections. Rheumatol Ther. 2021;8(3):1051\u20139.","journal-title":"Rheumatol Ther"},{"issue":"2","key":"9827_CR42","doi-asserted-by":"publisher","first-page":"e002738","DOI":"10.1136\/rmdopen-2022-002738","volume":"9","author":"G Guggino","year":"2023","unstructured":"Guggino G, Rizzo C, Mohammadnezhad L, Lo Pizzo M, Lentini VL, Di Liberto D, et al. Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. RMD Open. 2023;9(2):e002738.","journal-title":"RMD Open"},{"issue":"24","key":"9827_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413325","volume":"22","author":"R Wilbrink","year":"2021","unstructured":"Wilbrink R, Spoorenberg A, Verstappen GM, Kroese FG. B cell involvement in the pathogenesis of ankylosing spondylitis. Int J Mol Sci. 2021;22(24):13325.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"9827_CR44","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1002\/jcp.30313","volume":"236","author":"L Liu","year":"2021","unstructured":"Liu L, Yuan Y, Zhang S, Xu J, Zou J. Osteoimmunological insights into the pathogenesis of ankylosing spondylitis. J Cell Physiol. 2021;236(9):6090\u2013100.","journal-title":"J Cell Physiol"},{"key":"9827_CR45","doi-asserted-by":"crossref","unstructured":"Ahmed SS, Abed RM. Evaluating the Serum Level of IL-40 in a Sample of Iraqi Men with Ankylosing Spondylitis. Iraqi J Sci. 2024.","DOI":"10.24996\/ijs.2024.65.12.13"},{"key":"9827_CR46","doi-asserted-by":"publisher","unstructured":"Jaber AS, Ad\u2019hiah AH. A novel signature of interleukins 36\u03b1, 37, 38, 39 and 40 in ankylosing spondylitis. Cytokine. 2023;162:156117. https:\/\/doi.org\/10.1016\/j.cyto.2022.156117.","DOI":"10.1016\/j.cyto.2022.156117"},{"key":"9827_CR47","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1136\/annrheumdis-2024-eular.5225","volume":"83","author":"L Ondrej\u010d\u00e1kov\u00e1","year":"2024","unstructured":"Ondrej\u010d\u00e1kov\u00e1 L, Navr\u00e1tilov\u00e1 A, Gregov\u00e1 M, Bubova K, Grega T, \u0160enolt L, et al. AB0927 serum Interleukin-40 levels in patients with inflammatory bowel diseases-associated spondyloarthritis: a preliminary study. Ann Rheum Dis. 2024;83:1772\u20133.","journal-title":"Ann Rheum Dis"},{"key":"9827_CR48","doi-asserted-by":"crossref","unstructured":"Murad R, Genetic polymorphism of Abedr, IL-40 in male patients with ankylosing spondylitis. South East Eur J PUBLIC Health. 2024;87\u201397.","DOI":"10.70135\/seejph.vi.1648"},{"key":"9827_CR49","doi-asserted-by":"crossref","unstructured":"Abed RM, Abdulmalek HW, Yaaqoob LA, Altaee MF, Kamona ZK. Serum level and genetic polymorphism of IL-38 and IL-40 in autoimmune thyroid disease. Iraqi J Sci. 2023;2786\u201397.","DOI":"10.24996\/ijs.2023.64.6.12"},{"key":"9827_CR50","unstructured":"Hussain ZK. Immunological and Metabolic changes in Iraqi Women Patient with Graves\u2019 disease. 2024."},{"issue":"1","key":"9827_CR51","first-page":"100171","volume":"2","author":"RR Ghamyes","year":"2025","unstructured":"Ghamyes RR, Bani-Wais DF, Nijeeb RA, Bashi MA, Kadhim NT, Ad\u2019hiah AH. Evaluation of interleukin-40 levels in serum of patients with psoriasis and psoriatic arthritis. Res. 2025;2(1):100171.","journal-title":"Res"},{"issue":"1","key":"9827_CR52","first-page":"1","volume":"6","author":"AA Ghani","year":"2025","unstructured":"Ghani AA, Ahmed ZAR. Assessment of Serum Interleukin 40 and 41 Levels in Patients with Multiple Sclerosis. J Wet Health. 2025;6(1):1\u20137.","journal-title":"J Wet Health"},{"key":"9827_CR53","doi-asserted-by":"publisher","unstructured":"Neamah MZ, Sharquie IK, Al Gawwam G. Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients. Medeni Med J. 2025;40(4):226\u201334. https:\/\/doi.org\/10.4274\/MMJ.galenos.2025.48830.","DOI":"10.4274\/MMJ.galenos.2025.48830"},{"key":"9827_CR54","doi-asserted-by":"publisher","unstructured":"Vasi \u0130, Ba\u011fr\u0131a\u00e7\u0131k E\u00dc, Karda\u015f RC, \u00d6r\u00fckl\u00fc N, Yaman M, Y\u0131ld\u0131r\u0131m D, et al. Interleukin-40 in Systemic Sclerosis: A Treatment-Sensitive Marker of Immune Modulation Rather Than Disease Activity. Clin Transl Sci. 2026;19(8):e70678. https:\/\/doi.org\/10.1111\/cts.70678.","DOI":"10.1111\/cts.70678"},{"issue":"1","key":"9827_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-025-03570-3","volume":"27","author":"A Navr\u00e1tilov\u00e1","year":"2025","unstructured":"Navr\u00e1tilov\u00e1 A, Oresk\u00e1 S, W\u00fcnsch H, Mocov\u00e1 K, Kodet O, Rybar M, et al. Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes. Arthritis Res Ther. 2025;27(1):119. https:\/\/doi.org\/10.1186\/s13075-025-03570-3 . PubMed PMID: 40457473; PubMed Central PMCID: PMC12128543.","journal-title":"Arthritis Res Ther"},{"key":"9827_CR56","doi-asserted-by":"publisher","unstructured":"Ahmadi P, Honardoost M, Janzadeh A, Taherkhani S. Flavonoids and Their Influence on the Gut Microbiome: Implications for Cardiovascular Health. Nutr Bull. 2026;51(1):5\u201337. https:\/\/doi.org\/10.1111\/nbu.70039.","DOI":"10.1111\/nbu.70039"},{"key":"9827_CR57","doi-asserted-by":"publisher","unstructured":"Taherkhani S, Ahmadi P, Nasiraie LR, Janzadeh A, Honardoost M, Sedghi Esfahani S. Flavonoids and the gut microbiome: a powerful duo for brain health. Crit Rev Food Sci Nutr. 2025;65(28):6029\u201344. https:\/\/doi.org\/10.1080\/10408398.2024.2435593.","DOI":"10.1080\/10408398.2024.2435593"},{"key":"9827_CR58","doi-asserted-by":"publisher","unstructured":"Ahmadi P, Mahmoudi M, Mozaffari-Jovin S, Kheder RK, Faraj TA, Mollazadeh S, et al. The Impact of Oral-Gut Microbiota Structure and Its Manipulation on RA Development and Management. Food Sci Nutr. 2026;14(8):e72090. https:\/\/doi.org\/10.1002\/fsn3. 72090 PubMed PMID: 42540216; PubMed Central PMCID: PMC13425616.","DOI":"10.1002\/fsn3"},{"key":"9827_CR59","doi-asserted-by":"publisher","unstructured":"Javanmardi Z, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Shapouri-Moghaddam A, Ahmadi P, et al. Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti-inflammatory profile of macrophages-derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochem Funct. 2024;42(2):e3981. https:\/\/doi.org\/10.1002\/cbf.3981.","DOI":"10.1002\/cbf.3981"},{"key":"9827_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365554","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Yuan W, Yang C, Wang Z, Zhang J, Xu D, et al. Emerging role of gut microbiota in autoimmune diseases. Front Immunol. 2024;15:1365554.","journal-title":"Front Immunol"},{"key":"9827_CR61","doi-asserted-by":"publisher","unstructured":"Navr\u00e1tilov\u00e1 A, Be\u010dv\u00e1\u0159 V, Hulejov\u00e1 H, Tom\u010d\u00edk M, \u0160tolov\u00e1 L, Mann H, et al. New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis. RMD Open. 2023;9(2). https:\/\/doi.org\/10.1136\/rmdopen-2022-002894.","DOI":"10.1136\/rmdopen-2022-002894"},{"key":"9827_CR62","doi-asserted-by":"crossref","unstructured":"Cerezo LA, Baloun J, Navr\u00e1tilov\u00e1 A, Kropackova T, Pavelka K, Vencovsk\u00fd J, et al. ABS0285 reduction in elevated serum IL-40 levels after 3 months of tnf inhibitor therapy as a potential predictor of one-year clinical improvement in rheumatoid arthritis patients. Ann Rheum Dis. 2025;84:1955.","DOI":"10.1016\/j.ard.2025.06.1509"},{"key":"9827_CR63","doi-asserted-by":"crossref","unstructured":"Xiang N, Hao X, Chuang G, Wang L, Zhou Z, Wang G, et al. POS0102 global characterization of salivary glands immune microenvironment in primary Sj\u00f6gren\u2019s syndrome by single-cell sequencing. Ann Rheum Dis. 2022;81:273.","DOI":"10.1136\/annrheumdis-2022-eular.4195"},{"key":"9827_CR64","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ard.2025.05.965","volume":"84","author":"\u0130 Vasi","year":"2025","unstructured":"Vasi \u0130, Bagriacik E, Karda\u015f R, Oruklu N, Yaman M, Karakus R, et al. POS0583 IL-40: a novel proinflammatory B cell-associated cytokine and its role in systemic sclerosis. Ann Rheum Dis. 2025;84:783\u20134.","journal-title":"Ann Rheum Dis"},{"key":"9827_CR65","unstructured":"Abed NN, Muttaleb NS, Interleukin-40 as, a predictive tool of, response to treatment for insulin resistance in patients with type 2 diabetes, Cah. MAGELLANES-NS. 2024;6(2):3635\u201342."},{"key":"9827_CR66","doi-asserted-by":"publisher","DOI":"10.21608\/ejmm.2025.371959.1540","author":"H Abdulraheem","year":"2025","unstructured":"Abdulraheem H, AL-Hasnawi SMJ, Ali MM. Diagnostic potential of interleukin-40 and interleukin-41 in diabetic kidney disease. Egypt J Med Microbiol. 2025. https:\/\/doi.org\/10.21608\/ejmm.2025.371959.1540.","journal-title":"Egypt J Med Microbiol"},{"issue":"6","key":"9827_CR67","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45(6):580\u20135.","journal-title":"Nat Genet"},{"issue":"9","key":"9827_CR68","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10067-006-0532-7","volume":"26","author":"JK King","year":"2007","unstructured":"King JK, Costenbader KH. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin\u2019s lymphoma (NHL). Clin Rheumatol. 2007;26(9):1491\u20134. https:\/\/doi.org\/10.1007\/s10067-006-0532-7 . PubMed PMID: 17297594.","journal-title":"Clin Rheumatol"},{"issue":"11","key":"9827_CR69","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024;20(11):729\u201340. https:\/\/doi.org\/10.1038\/s41584-024-01167-9 . PubMed PMID: 39390260.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"9827_CR70","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/03009749709065678","volume":"26","author":"M Jeffers","year":"1997","unstructured":"Jeffers M, Crilly A, Kerr T, Richmond J, Madhok R. Non-Hodgkin\u2019s lymphomas complicating Sj\u00f6gren\u2019s syndrome: can Epstein Barr virus be implicated? Scand J Rheumatol. 1997;26(3):180\u20133. doi:10.3109\/03009749709065678 PubMed PMID: 9225872.","journal-title":"Scand J Rheumatol"},{"issue":"824","key":"9827_CR71","doi-asserted-by":"publisher","first-page":"eady0210","DOI":"10.1126\/scitranslmed.ady0210","volume":"17","author":"S Younis","year":"2025","unstructured":"Younis S, Moutusy SI, Rasouli S, Jahanbani S, Pandit M, Wu X, et al. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus. Sci Transl Med. 2025;17(824):eady0210. https:\/\/doi.org\/10.1126\/scitranslmed.ady0210 . PubMed PMID: 41223250; PubMed Central PMCID: PMC12740198.","journal-title":"Sci Transl Med"},{"issue":"W1","key":"9827_CR72","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"key":"9827_CR73","doi-asserted-by":"publisher","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of Non-Hodgkin\u2019s Lymphoma. Med Sci Basel Switz. 2021;9(1). https:\/\/doi.org\/10.3390\/medsci9010005.","DOI":"10.3390\/medsci9010005"},{"issue":"9","key":"9827_CR74","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.4049\/jimmunol.1700534","volume":"199","author":"J Catalan-Dibene","year":"2017","unstructured":"Catalan-Dibene J, Vazquez MI, Luu VP, Nuccio SP, Karimzadeh A, Kastenschmidt JM, et al. Identification of IL-40, a novel B cell\u2013associated cytokine. J Immunol. 2017;199(9):3326\u201335.","journal-title":"J Immunol"},{"issue":"1","key":"9827_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21608\/blj.2020.146586","volume":"16","author":"NM Said","year":"2020","unstructured":"Said NM, Yassin F, Esh AM, Saeed E. Association between serum level of pentraxin-3 and interleukin-40 with HCC disease in Egypt. Biochem Lett. 2020;16(1):50\u201362.","journal-title":"Biochem Lett"},{"key":"9827_CR76","doi-asserted-by":"publisher","unstructured":"Sagmeister P, Daza J, Ofner A, Ziesch A, Ye L, Ben Khaled N, et al. Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis. J Hepatocell Carcinoma. 2022;9:595\u2013607. https:\/\/doi.org\/10.2147\/JHC.S356333","DOI":"10.2147\/JHC.S356333"},{"key":"9827_CR77","doi-asserted-by":"publisher","unstructured":"G\u00fcl\u00e7ek E, Aydo\u011fdu YF, Emreol U\u0130, Ba\u011fr\u0131a\u00e7\u0131k E\u00dc, Aky\u00fcrek N. Investigation of pre and postoperative Th1\/Th2 cytokine balance and novel cytokines in colorectal cancer patients. Clin Exp Med. 2024;24(1):211. https:\/\/doi.org\/10.1007\/s10238-024-01480-3.","DOI":"10.1007\/s10238-024-01480-3"},{"key":"9827_CR78","doi-asserted-by":"publisher","unstructured":"Dabbagh-Gorjani F. A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases. Autoimmune Dis. 2024;2024:3968767. https:\/\/doi.org\/10.1155\/2024\/3968767","DOI":"10.1155\/2024\/3968767"},{"key":"9827_CR79","doi-asserted-by":"publisher","unstructured":"Babun FK, Kayar NA, Hatipo\u011flu M. Investigating the role of salivary Interleukin-40 levels in diagnosing periodontal diseases. Oral Dis. 2024;30(8):5315\u201325. https:\/\/doi.org\/10.1111\/odi.14936.","DOI":"10.1111\/odi.14936"},{"key":"9827_CR80","doi-asserted-by":"publisher","unstructured":"Oruc AH, Babayi\u011fit O, Salivary asprosin. IL-39, IL-40, and IL-1\u03b2 levels in diabetic patients with periodontitis: A cross-sectional analysis. Clin Oral Investig. 2026;30(1):52. https:\/\/doi.org\/10.1007\/s00784-026-06744-8.","DOI":"10.1007\/s00784-026-06744-8"},{"key":"9827_CR81","doi-asserted-by":"publisher","unstructured":"Shekho CK, Hamza MA. The Novel Log(10)(Lymphocyte\/MID%) ratio outperforms CRP and traditional inflammatory indices as a diagnostic biomarker for metabolic syndrome in postmenopausal women. J Investig Med Off Publ Am Fed Clin Res. 2026;10815589261448840. https:\/\/doi.org\/10.1177\/10815589261448840","DOI":"10.1177\/10815589261448840"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09827-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09827-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09827-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:37:47Z","timestamp":1787377067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09827-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9827"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09827-6","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors listed on the manuscript have agreed to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}